Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation

被引:4
|
作者
Carrero, Juan Jesus [1 ]
Trevisan, Marco [1 ]
Evans, Marie [2 ]
Svennberg, Emma [3 ]
Szummer, Karolina [4 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Karolinska Univ Hosp Huddinge, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
[3] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Cardiol, Solna, Sweden
[5] Karolinska Inst, Dept Med, Huddinge, Sweden
基金
瑞典研究理事会;
关键词
Kidney function; Atrial fibrillation; Heart failure; Outcomes; PROGNOSTIC IMPLICATIONS; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS; PREDICTORS; MORTALITY; ADULTS; DEATH;
D O I
10.1016/j.ijcard.2020.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Heart failure (HF) is the most common complication of patients with atrial fibrillation (AF), but possible risk factors or health consequences are not well described. Low kidney function is a risk factor for both AF and HF. We evaluated estimated glomerular filtration rate (eGFR) as a predictor of HF in patients with AF, and then quantified the adverse health outcomes associated to incident HF. Methods and results: This is an observational analysis of 19,662 adults without a previous history of HF who had new-onset AF in Stockholm healthcare (Sweden) during 2007-2011. During a median of 713 (IQR 281-1253) days of follow up, 3342 (16.4%) patients developed HF, with incidence rate of 7.4 per 100-person-years (95% CI 7.2-7.7). In Cox regression, eGFR was linearly associated with subsequent HF risk. Compared to eGFR=60 ml/min/1.73 m(2), patients with eGFR 30-59 and eGFR<30 ml/min/1.73 m(2) had 13% (HR 1.13; 95% CI 1.04-1.23) and 53% (HR 1.53; 1.25-1.88) higher risk of HF. Results were consistent across various pre-specified subgroups and after excluding early events. Compared to non-HF, developing HF (as a time-varying exposure) was associated with a 5-fold (HR 5.05; 4.07-6.28) higher risk of subsequent kidney function decline, a 1.5 times higher risk of stroke (HR 1.54; 1.35-1.76), and a doubling in the risk ofmyocardial infarction (HR 2.21; 1.87-2.62) and death (HR 2.17; 2.01-2.33). Conclusion: In patients with AF, low kidney function associates with the risk of HF. Developing HF heightened the subsequent risk of kidney function decline, cardiovascular event and death. (C) 2020 Published by Elsevier B.V.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 50 条
  • [1] Kidney function and heart failure risk in patients with new-onset atrial fibrillation
    Szummer, K.
    Trevisan, M.
    Evans, M.
    Svennberg, E.
    Carrero, J. J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 343 - 344
  • [2] Is New-Onset Atrial Fibrillation Bad News for Patients With Heart Failure?
    Iguchi, Moritake
    Akao, Masaharu
    [J]. CIRCULATION JOURNAL, 2015, 80 (01) : 62 - 63
  • [3] Left Atrial Strain as a Predictor of New-Onset Atrial Fibrillation in Patients With Heart Failure
    Park, Jin Joo
    Park, Jae-Hyeong
    Hwang, In-Chang
    Park, Jun-Bean
    Cho, Goo-Yeong
    Marwick, Thomas H.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2020, 13 (10) : 2071 - 2081
  • [4] Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation
    Azadani, Peyman N.
    King, Jordan B.
    Kheirkhahan, Mobin
    Chang, Lowell
    Marrouche, Nassir F.
    Wilson, Brent D.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 161 - 165
  • [5] New-onset Atrial Fibrillation Predicts Heart Failure Progression
    Aleong, Ryan G.
    Sauer, William H.
    Davis, Gordon
    Bristow, Michael R.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2014, 127 (10): : 963 - 971
  • [6] The prospective effect of lipoprotein(a) on new-onset atrial fibrillation in patients with chronic heart failure
    Li, Wen-Jia
    Li, Ming-Hong
    Yin, Rui
    Cui, Yu-Qi
    Yin, Lei
    Jiang, Shi-Liang
    Cui, Lian-Qun
    Chen, Li-Ming
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 18316 - 18323
  • [7] Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
    Hu, Yu-feng
    Liu, Chia-jen
    Chang, Peter Mu-hsin
    Tsao, Hsuan-ming
    Lin, Yenn-jiang
    Chang, Shih-lin
    Lo, Li-wei
    Tuan, Ta-chuan
    Li, Cheng-hung
    Chao, Tze-fan
    Chung, Fa-po
    Liao, Jo-nan
    Chen, Tzeng-Ji
    Chen, Shih-ann
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 165 (02) : 355 - 357
  • [8] Dapagliflozin effect on heart failure with prevalent or new-onset atrial fibrillation
    Arita, Vicente Artola
    Van Veldhuisen, Dirk J.
    Rienstra, Michiel
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 526 - 528
  • [9] Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
    Choi, Hyo-In
    Lee, Sang Eun
    Kim, Min-Seok
    Lee, Hae-Young
    Cho, Hyun-Jai
    Choi, Jin Oh
    Jeon, Eun-Seok
    Hwang, Kyung-Kuk
    Chae, Shung Chull
    Baek, Sang Hong
    Kang, Seok-Min
    Choi, Dong-Ju
    Yoo, Byung-Su
    Kim, Kye Hun
    Cho, Myeong-Chan
    Oh, Byung-Hee
    Kim, Jae-Joong
    [J]. LIFE-BASEL, 2022, 12 (04):
  • [10] Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation
    Debonnaire, Philippe
    Joyce, Emer
    Hiemstra, Yasmine
    Mertens, Bart J.
    Atsma, Douwe E.
    Schalij, Martin J.
    Bax, Jeroen J.
    Delgado, Victoria
    Marsan, Nina Ajmone
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (02):